The median age of patients with severe HA hepatitis (regardless of liver dysfunction) was markedly lower than that of HAV-IgM (+) non-severe patients (36/31.5 vs. 63 years, p < 0.001). This evidence concerns the gene CD40LG and Decreased liver function.